ChemoPAD team's Lancet Global Health paper is out!
This systematic study of the quality of small-molecule anti-cancer drugs in four countries in sub-Saharan Africa shows serious problems are present that could impact patient care outcomes.
The manuscript was published in The Lancet Global Health. Shout out to the co-authors who did the hard work of collecting these samples from multiple hospitals and private/community pharmacies and particularly to Max Wilfinger, the first author of the study, who did the bulk of the chemical analysis.
Originally published by at padproject.nd.edu on June 25, 2025.